{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:54:11Z","timestamp":1781610851421,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00787-026-02961-4","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:50:28Z","timestamp":1768391428000},"page":"1511-1519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antidepressant use in German adolescents with a first recorded diagnosis of depression: a retrospective cohort study"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-7227","authenticated-orcid":false,"given":"Karel","family":"Kostev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Doege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2961_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Q Liu","year":"2020","unstructured":"Liu Q, He H, Yang J et al (2020) Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study. J Psychiatr Res 126:134\u2013140. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.002","journal-title":"J Psychiatr Res"},{"key":"2961_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bjc.12333","volume":"61","author":"S Shorey","year":"2022","unstructured":"Shorey S, Ng ED, Wong CHJ (2022) Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis. Br J Clin Psychol 61:287\u2013305. https:\/\/doi.org\/10.1111\/bjc.12333","journal-title":"Br J Clin Psychol"},{"key":"2961_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jad.2020.03.082","volume":"271","author":"A Steffen","year":"2020","unstructured":"Steffen A, Thom J, Jacobi F et al (2020) Trends in prevalence of depression in Germany between 2009 and 2017 based on nationwide ambulatory claims data. J Affect Disord 271:239\u2013247. https:\/\/doi.org\/10.1016\/j.jad.2020.03.082","journal-title":"J Affect Disord"},{"key":"2961_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013674.pub2","author":"SE Hetrick","year":"2021","unstructured":"Hetrick SE, McKenzie JE, Bailey AP et al (2021) New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Reviews. https:\/\/doi.org\/10.1002\/14651858.CD013674.pub2","journal-title":"Cochrane Database Syst Reviews"},{"key":"2961_CR5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/pds.3295","volume":"21","author":"F Hoffmann","year":"2012","unstructured":"Hoffmann F, Glaeske G, Petermann F, Bachmann CJ (2012) Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data. Pharmacoepidemiol Drug Saf 21:972\u2013979. https:\/\/doi.org\/10.1002\/pds.3295","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2961_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","volume":"26","author":"CJ Bachmann","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M et al (2016) Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012. Eur Neuropsychopharmacol 26:411\u2013419. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.02.001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"2961_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00787-024-02433-7","volume":"34","author":"L Rasmussen","year":"2025","unstructured":"Rasmussen L, Jensen PB, Reutfors J et al (2025) Treatment patterns of antidepressants in children and adolescents in Scandinavia. Eur Child Adolesc Psychiatry 34(1):159\u2013167. https:\/\/doi.org\/10.1007\/s00787-024-02433-7","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"10","key":"2961_CR8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3346\/jkms.2017.32.10.1694","volume":"32","author":"MW Chon","year":"2017","unstructured":"Chon MW, Lee J, Chung S et al (2017) Prescription pattern of antidepressants for children and adolescents in Korea based on nationwide data. J Korean Med Sci 32(10):1694\u20131701. https:\/\/doi.org\/10.3346\/jkms.2017.32.10.1694","journal-title":"J Korean Med Sci"},{"key":"2961_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/cap.2006.16.197","volume":"16","author":"JM Fegert","year":"2006","unstructured":"Fegert JM, K\u00f6lch M, Zito JM et al (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197\u2013206. https:\/\/doi.org\/10.1089\/cap.2006.16.197","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2961_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5414\/CP203320","volume":"56","author":"W Rathmann","year":"2018","unstructured":"Rathmann W, Bongaerts B, Carius H-J et al (2018) Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther 56:459\u2013466. https:\/\/doi.org\/10.5414\/CP203320","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2961_CR11","doi-asserted-by":"publisher","first-page":"14509","DOI":"10.1007\/s00432-023-05229-5","volume":"149","author":"H Moessinger","year":"2023","unstructured":"Moessinger H, Jacob L, Smith L et al (2023) Psychiatric disorder and its association with gastrointestinal cancer: a retrospective cohort study with 45,842 patients in Germany. J Cancer Res Clin Oncol 149:14509\u201314518. https:\/\/doi.org\/10.1007\/s00432-023-05229-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"2961_CR12","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2174\/1381612828666220526150153","volume":"28","author":"G Masi","year":"2022","unstructured":"Masi G (2022) Controversies in the pharmacotherapy of adolescent depression. Curr Pharm Des 28:1975\u20131984. https:\/\/doi.org\/10.2174\/1381612828666220526150153","journal-title":"Curr Pharm Des"},{"key":"2961_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00115-018-0539-8","volume":"89","author":"D Anheyer","year":"2018","unstructured":"Anheyer D, Haller H, Klose P et al (2018) Phytotherapie bei psychiatrischen Erkrankungen. Nervenarzt 89:1009\u20131013. https:\/\/doi.org\/10.1007\/s00115-018-0539-8","journal-title":"Nervenarzt"},{"key":"2961_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01951-9","volume":"12","author":"T Teng","year":"2022","unstructured":"Teng T, Zhang Z, Yin B et al (2022) Effect of antidepressants on functioning and quality of life outcomes in children and adolescents with major depressive disorder: a systematic review and meta-analysis. Transl Psychiatry 12:183. https:\/\/doi.org\/10.1038\/s41398-022-01951-9","journal-title":"Transl Psychiatry"},{"key":"2961_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/0018578720925384","volume":"56","author":"AA Reyad","year":"2021","unstructured":"Reyad AA, Plaha K, Girgis E, Mishriky R (2021) Fluoxetine in the management of major depressive disorder in children and adolescents: a meta-analysis of randomized controlled trials. Hosp Pharm 56:525\u2013531. https:\/\/doi.org\/10.1177\/0018578720925384","journal-title":"Hosp Pharm"},{"key":"2961_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174465","volume":"910","author":"C Bis-Humbert","year":"2021","unstructured":"Bis-Humbert C, Garc\u00eda-Cabrerizo R, Garc\u00eda-Fuster MJ (2021) Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: comparison with adult rats. Eur J Pharmacol 910:174465. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174465","journal-title":"Eur J Pharmacol"},{"key":"2961_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","volume":"388","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C et al (2016) Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 388:881\u2013890. https:\/\/doi.org\/10.1016\/S0140-6736(16)30385-3","journal-title":"Lancet"},{"key":"2961_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/CHI.0b013e3181a2b304","volume":"48","author":"GJ Emslie","year":"2009","unstructured":"Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S (2009) Escitalopram in the treatment of adolescent depression: A randomized Placebo-Controlled multisite trial. J Am Acad Child Adolesc Psychiatry 48:721\u2013729. https:\/\/doi.org\/10.1097\/CHI.0b013e3181a2b304","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2961_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004851.pub3","author":"SE Hetrick","year":"2012","unstructured":"Hetrick SE, McKenzie JE, Cox GR et al (2012) Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004851.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2961_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00103-023-03721-4","volume":"66","author":"G Schulte-K\u00f6rne","year":"2023","unstructured":"Schulte-K\u00f6rne G, Klingele C, Zsigo C, Kloek M (2023) S3-Leitlinie depressive St\u00f6rungen Im Kindes- und jugendalter: Wo geht Es hin? Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 66:767\u2013773. https:\/\/doi.org\/10.1007\/s00103-023-03721-4","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"2961_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00787-013-0395-9","volume":"22","author":"M D\u00f6rks","year":"2013","unstructured":"D\u00f6rks M, Langner I, Dittmann U et al (2013) Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Eur Child Adolesc Psychiatry 22:511\u2013518. https:\/\/doi.org\/10.1007\/s00787-013-0395-9","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2961_CR22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/pds.4289","volume":"26","author":"C Schr\u00f6der","year":"2017","unstructured":"Schr\u00f6der C, D\u00f6rks M, Kollhorst B et al (2017) Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011. Pharmacoepidemiol Drug Saf 26:1395\u20131402. https:\/\/doi.org\/10.1002\/pds.4289","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2961_CR23","first-page":"315","volume":"20","author":"C Carandang","year":"2011","unstructured":"Carandang C, Jabbal R, Macbride A, Elbe D (2011) A review of Escitalopram and Citalopram in child and adolescent depression. J Can Acad Child Adolesc Psychiatry 20:315\u2013324","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"9","key":"2961_CR24","first-page":"26","volume":"18","author":"JB Dwyer","year":"2019","unstructured":"Dwyer JB, Bloch MH (2019) Antidepressants for Pediatric Patients. Curr Psychiatry 18(9):26-42F","journal-title":"Curr Psychiatry"},{"issue":"7","key":"2961_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou X, Teng T, Zhang Y et al (2020) Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 7(7):581\u2013601. https:\/\/doi.org\/10.1016\/S2215-0366(20)30137-1","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"2961_CR26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(21)00154-1","volume":"8","author":"SE Murphy","year":"2021","unstructured":"Murphy SE, Capit\u00e3o LP, Giles SL et al (2021) The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action. Lancet Psychiatry 8(9):824\u2013835. https:\/\/doi.org\/10.1016\/S2215-0366(21)00154-1","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"2961_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/pds.1405","volume":"16","author":"M Ufer","year":"2007","unstructured":"Ufer M, Meyer SA, Junge O et al (2007) Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 16(10):1153\u20131160. https:\/\/doi.org\/10.1002\/pds.1405","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2961_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0325-2","volume":"5","author":"EA Apaydin","year":"2016","unstructured":"Apaydin EA, Maher AR, Shanman R et al (2016) A systematic review of St. John\u2019s wort for major depressive disorder. Syst Rev 5(1):148. https:\/\/doi.org\/10.1186\/s13643-016-0325-2","journal-title":"Syst Rev"},{"issue":"2","key":"2961_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/cap.2005.15.293","volume":"15","author":"J Simeon","year":"2005","unstructured":"Simeon J, Nixon MK, Milin R et al (2005) Open-label pilot study of St. John\u2019s wort in adolescent depression. J Child Adolesc Psychopharmacol 15(2):293\u2013301. https:\/\/doi.org\/10.1089\/cap.2005.15.293","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2961_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18052779","author":"J Sander","year":"2021","unstructured":"Sander J, Moessner M, Bauer S (2021) Depression, anxiety and eating disorder-related impairment: moderators in female adolescents and young adults. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18052779","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2961_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-023-00713-7","volume":"24","author":"S Yu","year":"2023","unstructured":"Yu S, Zhang Y, Shen C, Shao F (2023) Efficacy of pharmacotherapies for bulimia nervosa: a systematic review and meta-analysis. BMC Pharmacol Toxicol 24(1):72. https:\/\/doi.org\/10.1186\/s40360-023-00713-7","journal-title":"BMC Pharmacol Toxicol"},{"key":"2961_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.949823","volume":"13","author":"H Duan","year":"2022","unstructured":"Duan H, Zhu L, Li M et al (2022) Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: a network meta-analysis. Front Pharmacol 13:949823. https:\/\/doi.org\/10.3389\/fphar.2022.949823","journal-title":"Front Pharmacol"},{"issue":"1","key":"2961_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5114\/ppn.2023.127237","volume":"32","author":"GI Costandache","year":"2023","unstructured":"Costandache GI, Munteanu O, Salaru A, Oroian B, Cozmin M (2023) An overview of the treatment of eating disorders in adults and adolescents: pharmacology and psychotherapy. Postepy Psychiatr Neurol 32(1):40\u201348. https:\/\/doi.org\/10.5114\/ppn.2023.127237","journal-title":"Postepy Psychiatr Neurol"},{"key":"2961_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/da.22737","volume":"35","author":"YA de Vries","year":"2018","unstructured":"de Vries YA, Roest AM, Burgerhof JGM, Jonge P (2018) Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: an individual patient data meta-analysis. Depress Anxiety 35:515\u2013522. https:\/\/doi.org\/10.1002\/da.22737","journal-title":"Depress Anxiety"},{"key":"2961_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.psc.2022.11.005","volume":"46","author":"C Pittenger","year":"2023","unstructured":"Pittenger C (2023) The pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am 46:107\u2013119. https:\/\/doi.org\/10.1016\/j.psc.2022.11.005","journal-title":"Psychiatr Clin North Am"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-02961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-02961-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-02961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:20:00Z","timestamp":1781608800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-026-02961-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2961"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-02961-4","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}